子宮内膜癌,子宮内膜増殖症のDNA ploidyとHER-2/neu protein過剰発現についての検討

作者: Akihiko WATANABE , Hiroshi SASAKI

DOI: 10.5795/JJSCC.33.612

关键词: Her 2 neuMolecular biologyMedicineDna ploidy

摘要:

参考文章(14)
D. Chin, R. Ortiz, J. W. Bacus, D. S. Weinberg, S. S. Bacus, S. G. Ruby, HER-2/neu oncogene expression and proliferation in breast cancers. American Journal of Pathology. ,vol. 137, pp. 103- 111 ,(1990)
Michael L. Berman, Samuel C. Ballon, Leo D. Lagasse, Watson G. Watring, Prognosis and treatment of endometrial cancer American Journal of Obstetrics and Gynecology. ,vol. 136, pp. 679- 688 ,(1980) , 10.1016/0002-9378(80)91024-8
Alan L. Schechter, David F. Stern, Lalitha Vaidyanathan, Stuart J. Decker, Jeffrey A. Drebin, Mark I. Greene, Robert A. Weinberg, The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen. Nature. ,vol. 312, pp. 513- 516 ,(1984) , 10.1038/312513A0
William T. Creasman, C. Paul Morrow, Brian N. Bundy, Howard D. Homesley, James E. Graham, Paul B. Heller, Surgical pathologic spread patterns of endometrial cancer: A gynecologic oncology group study Cancer. ,vol. 60, pp. 2035- 2041 ,(1987) , 10.1002/1097-0142(19901015)60:8+<2035::AID-CNCR2820601515>3.0.CO;2-8
Andrew Berchuck, Gene P. Siegal, Masakuni Furusato, Yoshiteru Terashima, Matthew F. Kohler, Hiroshi Nishii, Hiroyuki Takahashi, Akio Tada, Sheryl L. Parker, Jeff Boyd, Hiroshi Sasaki, Mutation of the Ki-ras protooncogene in human endometrial hyperplasia and carcinoma. Cancer Research. ,vol. 53, pp. 1906- 1910 ,(1993)
M. Heatley, P. Maxwell, Ch. Whiteside, P.G. Toner, C-erbB-2 oncogene product expression depends on tumour type and is related to oestrogen receptor and lymph node status in human breast carcinoma. Pathology Research and Practice. ,vol. 189, pp. 261- 266 ,(1993) , 10.1016/S0344-0338(11)80508-X
Andrew Berchuck, Gus Rodriguez, Robert B. Kinney, John T. Soper, Richard K. Dodge, Daniel L. Clarke-Pearson, Robert C. Bast, Overexpression of HER-2/neu in endometrial cancer is associated with advanced stage disease. American Journal of Obstetrics and Gynecology. ,vol. 164, pp. 15- 21 ,(1991) , 10.1016/0002-9378(91)90615-X
Peter A. van Dam, David G. Lowe, James V. Watson, Matthew James, Tim Chard, Chris N. Hudson, John H. Shepherd, Multiparameter flow-cytometric quantitation of epidermal growth factor receptor and c-erbB-2 oncoprotein in normal and neoplastic tissues of the female genital tract Gynecologic Oncology. ,vol. 42, pp. 256- 264 ,(1991) , 10.1016/0090-8258(91)90355-9
LEON C. BRITTON, TIMOTHY O. WILSON, THOMAS A. GAFFEY, STEPHEN S. CHA, H. SAMUEL WIEAND, KARL C. PODRATZ, DNA Ploidy in Endometrial Carcinoma: Major Objective Prognostic Factor Mayo Clinic Proceedings. ,vol. 65, pp. 643- 650 ,(1990) , 10.1016/S0025-6196(12)65126-X
Antti J. I. Kauppila, Reijo K. Vihko, Seppo T. Kivinen, Hannu E. Isotalo, Prediction of clinical outcome with estrogen and progestin receptor concentrations and their relationships to clinical and histopathological variables in endometrial cancer. Cancer Research. ,vol. 46, pp. 5380- 5384 ,(1986)